Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery
Clinical trial NCT03148275 · COMPLETED
Trial details
- NCT number
- NCT03148275
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-20
- Primary completion
- 2023-06-23
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.